Coapt, LLC

Coapt, LLC, a Chicago-based for-profit limited liability company, manufactures advanced myoelectric control systems and prosthetic devices for upper limb prostheses, competing as a prime contractor in the open federal marketplace with no set-aside designations across its $10.4 million combined potential value footprint. The company has maintained a SAM.gov registration since 2012 and does not hold any parent contract vehicles or IDIQs; it competes exclusively through purchase orders and blanket purchase agreement calls issued directly by customer agencies.

Coapt's federal customer base concentrates heavily in health-related defense and veteran services. The Defense Health Agency anchors the footprint with 16 awards worth $8.8 million combined potential value—nearly 85 percent of total dollars across the vendor's prime and sub portfolio. Multiple Veterans Integrated Service Network regional offices within the Department of Veterans Affairs follow, with VISN 2 and VISN 8 each placing 14 awards in the $226,000 to $241,000 range, while VISN 10 has issued 8 awards. The Department of the Army Medical Command accounts for 8 awards worth $306 thousand. These five customers represent 94 percent of the vendor's combined potential value. Award concentration reflects Coapt's specialization in prosthetic component supply rather than systems integration or program-level services; individual purchase orders typically range from $13,000 to $67,000 for items such as custom artificial limbs, myoelectric control systems, hand and elbow prostheses, wrist components, and microprocessor prosthetic arms.

Coapt holds two blanket purchase agreements with the Defense Health Agency. The primary vehicle, BPA HT001419A0021 established in September 2019, carries a multi-year ceiling of $8 million and has generated 11 task orders worth $390 thousand in combined potential value. A successor BPA, HT001426AE010 awarded on January 19, 2026, carries a $350,000 ceiling through January 2029 and already has one task order outstanding. These BPAs function as standing supply arrangements rather than competitive vehicles; Coapt competes on the basis of its proprietary Complete Control system technology, which the source characterizes as compatible with over 400 combinations of powered hand, wrist, and elbow devices.

Activity has grown modestly and unevenly. Coapt received 8 awards in 2022, 9 in 2023, peaked at 15 in 2024, then declined to 9 in 2025 and 3 year-to-date in 2026. Only 3 awards (combined potential value $51 thousand) face ultimate completion in the next twenty-four months, creating minimal recompete cliff exposure. The vendor's federal grant footprint centers on a single National Institute of Child Health and Human Development project grant awarded May 17, 2023, for development of a web-based digital health portal integrating myoelectric prosthesis use data with cloud computing analytics and clinician dashboards; the grant runs through April 30, 2025. In this research effort, Coapt acts as co-recipient with Liberating Technologies, Inc. and clinical collaborators at the Shirley Ryan AbilityLab. Coapt also appears as a sub-recipient on a Henry M. Jackson Foundation grant awarded April 14, 2025, providing technical engineering to integrate the Mia multifunction prosthetic hand with Coapt's myoelectric pattern recognition system.

Coapt's footprint is categorized 88 awards under PSC Medical and Surgical Instruments, Equipment, and Supplies, with NAICS concentration split between Surgical Appliance and Supplies Manufacturing (46 awards) and Electromedical and Electrotherapeutic Apparatus Manufacturing (41 awards). The vendor competes in full-and-open competition with no set-aside activity, relying on its proprietary control system technology and established customer relationships to secure task orders against the Defense Health Agency BPAs and direct purchase orders from regional VA networks.